Professor Gunter von Minckwitz - Chairman of the German Breast Group
Prof. von Minckwitz discusses a trial investigating the use of capecitabine as a chemotherapeutic drug to treat breast cancer. This study did not show any incease in efficacy when capecitabine was used and did produce capecitabine specific toxicities.